Second Sight Medical Products Aktie
WKN DE: A3DTRX / ISIN: US92854B1098
11.06.2025 14:29:10
|
Vivani Medical Appoints Anthony Baldor To Succeed Brigid Makes As CFO
(RTTNews) - Vivani Medical, Inc. (VANI), a clinical-stage biopharmaceutical company, announced Wednesday the appointment of Anthony Baldor as Chief Financial Officer.
Baldor succeeds Brigid Makes, who has decided to retire from Vivani to focus on her board appointments and personal projects after a distinguished career and significant contributions to the Company. Makes will continue to serve in an advisory capacity during the transition.
Baldor brings more than 20 years of financial management experience in the biotechnology sector. Prior to joining Vivani, Baldor was CFO at Diakonos Oncology Corp., and Vice President of Corporate Strategy & Development at 4D Molecular Therapeutics, Inc.
His experience also includes positions at Jefferies Group LLC, BioInnovation Capital, LLC, RMI Partners, and Cequent Pharmaceuticals, Inc.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Second Sight Medical Products Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Second Sight Medical Products Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Second Sight Medical Products Inc Registered Shs | 1,17 | -1,68% |
|